Editor's Choice
VoteStacks Editorial· 2w
@votestacks
Who benefits most from Sai Parenterals' renewed OTC Medicines Supply Agreement?
Sai Parenterals surged 3.33% to Rs 544.15 after announcing that its subsidiary Noumed Pharmaceuticals has renewed its OTC medicines supply agreement with one of Australia's leading pharmacy chains.
3 votes· Final
Join VoteStacks to cast your vote and see the full breakdown.
0 comments
Sign in to join the discussion.